Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: Cancer. 2015 Aug 26;121(23):4165–4172. doi: 10.1002/cncr.29636

Table 1.

Evaluation of response using neuro-oncology criteria of tumor response for CNS tumors

Overall
Response
Target lesion
(up to 5
measurable
lesions)
Non Target
lesion
New lesion Neurologic
examination
scale
Corticosteroid
use
Complete response (CR) None None No +2, +1, 0, −1 No
Partial Response (PR) ≥ −50% Non-enhancing, improved, unchanged No +2, +1, 0, −1 Stable (<25% increase from baseline)
Progression (PD) ≥ +25% Worsened Yes −2 Increase (>25% increase from baseline)
Stable disease (SD)*
*

SD = Any other disease status not meeting criteria for CR, PR or PD; +2=definitely better, +1=possibly better, 0=unchanged, −1=possibly worse, −2=definitely worse.